Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
623
-
Total 13F shares, excl. options
-
138M
-
Shares change
-
-197K
-
Total reported value, excl. options
-
$9.98B
-
Value change
-
-$41.9M
-
Put/Call ratio
-
1.31
-
Number of buys
-
304
-
Number of sells
-
-327
-
Price
-
$72.13
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q1 2022
824 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q1 2022.
Teladoc Health, Inc. - Common Stock (TDOC) has 623 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138M shares
of 175M outstanding shares and own 78.88% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (19.5M shares), VANGUARD GROUP INC (13.2M shares), BAILLIE GIFFORD & CO (10.7M shares), BlackRock Inc. (10.7M shares), Sumitomo Mitsui Trust Holdings, Inc. (8.84M shares), Nikko Asset Management Americas, Inc. (8.45M shares), Kinnevik AB (publ) (3.68M shares), STATE STREET CORP (3.4M shares), Bank of New York Mellon Corp (2.83M shares), and CREDIT SUISSE AG/ (2.25M shares).
This table shows the top 623 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.